NM_007294.4:c.3748G>A

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BS3BP6_Very_Strong

The NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000306 (AC=494) in the gnomAD database across 1,614,032 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000371. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.E1250D: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 531374, 1 star); p.E1250D: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 141786, 1 star); p.E1250= (synonymous): Likely_benign (ClinVar VariationId 232493, 3 stars); p.E1250G: Uncertain_significance (ClinVar VariationId 2748795, 1 star); p.E1250A: Uncertain_significance (ClinVar VariationId 4842652, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Breast-ovarian cancer, familial, susceptibility to, 1 (brovca1); it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

BRCA1
NM_007294.4 missense

Predictors

6
13
REVEL: 0.36 : Uncertain

Clinical Significance

Benign reviewed by expert panel U:1B:34O:1

Conservation

PhyloP100: 0.505

Publications

17 publications found
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007294.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP6Reputable source reports benign
ClinVar ≥3 stars benign — very strong (BP6); ClinVar submissions overwhelmingly benign (≥10 total, ≥80% B/LB, <10% P/LP) — strong (BP6, count-based); ClinVar germline classification: Benign/Likely Benign, 3 star(s). ClinVar submissions strongly and reliably favor benignity (33/34 total B/LB)
BS3Functional studies show no damaging effect
Well-established functional study shows no damaging effect (BS3); SCV000494424: A heatmap of the unsupervised cluster analysis of several assays carried out by Loke et al 2015, showed that this missense variant clusters with WT BRCA1, Bouwman et al 2013 showed that the E1250K mutant protein behaves similarly to WT in a cisplatin (anticancer drug) sensitivity assay, and other studies have shown that it does not alter splicing and the protein is expressed at normal levels (Anczukow et al 2008).; SCV000591469: In addition, one functional study and three in silico studies all found the variant to be neutral (Bouwman 2013, Abkevich 2004 15235020, Lindor 2012, Tavtigian 2006).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BRCA1 NM_007294.4
MANE Select
HGVSc / HGVSpc.3748G>Ap.Glu1250Lys
Exon rankExon 10 of 23
missense
Prot: NP_009225.1
BRCA1 NM_001407581.1
HGVSc / HGVSpc.3748G>Ap.Glu1250Lys
Exon rankExon 10 of 24
missense
Prot: NP_001394510.1
BRCA1 NM_001407582.1
HGVSc / HGVSpc.3748G>Ap.Glu1250Lys
Exon rankExon 10 of 24
missense
Prot: NP_001394511.1

Ensembl Transcripts

BRCA1 ENST00000357654.9
MANE Select
HGVSc / HGVSpc.3748G>Ap.Glu1250Lys
Exon rankExon 10 of 23
missense
Prot: ENSP00000350283
BRCA1 ENST00000468300.6
TSL:1
HGVSc / HGVSpc.788-751G>A
Exon rankIntron 10 of 21
intron
Prot: ENSP00000417148
BRCA1 ENST00000591534.6
TSL:1
HGVSc / HGVSpc.-43-17262G>A
Exon rankIntron 1 of 10
intron
Prot: ENSP00000467329

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000158
AC:24
Hom:0
AN:152196
Cov:32
GnomAD2 exomes
AF: 0.000199
AC:50
AN:251234
GnomAD4 exome
AF: 0.000322
AC:470
Hom:0
AN:1461836
Cov:32
GnomAD4 genome
AF: 0.000158
AC:24
Hom:0
AN:152196
Cov:32
TOPMed (Bravo)
AF: 0.000155
AC:41
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.000220
AC:104
Hom:0
AN:473654
Local & regional cohorts 4 sources
ESP6500 (Exome Variant Server)
AF: 0.000308
AC:4
AN:13006
Korea4K (4,157 Koreans)
AF: 0.000138
AC:1
AN:7234
Turkish Variome
AF: 0.000177
AC:1
Hom:0
AN:5172
UK10K
AF: 0.000132
AC:1
AN:7562
Showing 10 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000990 *1111112 0.000681 *1217618
BipEx
(Bipolar disorder (including schizoaffective))
0.000633 1828420 0.000693 2028844
Epi25
(Epilepsy)
0.000167 741958 0.000164 1166888
SCHEMA
(Schizophrenia)
0.000292 35119702 0.000298 56188070
Showing 4 cohortsAllele count / allele number. *AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
10
not specified (12)
-
-
8
Breast-ovarian cancer, familial, susceptibility to, 1 (8)
-
-
4
Hereditary breast ovarian cancer syndrome (4)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
not provided (3)
-
-
2
Breast and/or ovarian cancer (2)
-
-
1
BRCA1-related cancer predisposition (1)
-
-
1
Breast neoplasm (1)
-
-
1
Malignant tumor of breast (1)

Computational Scores

AlphaGenome AVI
Benign9.2
AlphaMissense
Benign0.089
BayesDel_addAF
Benign-0.18T
BayesDel_noAF
Benign-0.18
CADD
Benign11
DANN
Uncertain0.99
DEOGEN2
Benign0.20T
Eigen
Benign-0.60
Eigen_PC
Benign-0.69
FATHMM_MKL
Benign0.082N
FuncVEP CTI
Benign0.00013
GPN-Star LLR
N/A-1.7
GPN-Star score
N/A1.7
LIST_S2
Uncertain0.86D
M_CAP
Uncertain0.26D
MetaRNN
Benign0.16T
MetaSVM
Benign-0.83T
Mutation Taster
N/A74/26polymorphism
MutationAssessor
Benign1.6L
PhyloP100
Benign0.51
popEVE
Benign-3.6
PrimateAI
Benign0.24T
PromoterAI
N/A-0.027Neutral
PROVEAN
Benign-0.71N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.0
REVEL
Uncertain0.36
Sift
Uncertain0.0020D
Sift4G
Uncertain0.048D
Varity_R
N/A0.054
VESM-3B
Benign-2.6
Showing 31 of 31 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Splicevardb
N/A1.0
Showing 3 of 3 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs28897686;
hg19: chr17-41243800;
COSMIC: COSV58788553;
COSMIC: COSV58788553;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.